HIGH-RISK LOCALIZED PROSTATE CANCER
Clinical trials for HIGH-RISK LOCALIZED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK LOCALIZED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HIGH-RISK LOCALIZED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a new combo slash hormone therapy time for prostate cancer?
Disease control Not yet recruitingThis study tests whether adding a targeted radiation drug (177Lu-PSMA-617) to standard radiation allows men with high-risk prostate cancer to take hormone therapy for only 6 months instead of the usual 24 months. The goal is to see if the shorter hormone course is just as effecti…
Matched conditions: HIGH-RISK LOCALIZED PROSTATE CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 06:18 UTC
-
New study tracks Real-World prostate cancer care to improve future treatments
Knowledge-focused Not yet recruitingThis study will follow 700 men with high-risk or metastatic prostate cancer to collect detailed information on how they are treated in everyday practice and how treatments affect their quality of life. Researchers will also gather blood and tissue samples to help discover new bio…
Matched conditions: HIGH-RISK LOCALIZED PROSTATE CANCER
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 06:21 UTC